HIGHLIGHTS
- who: Chronic myelomonocytic leukemia and colleagues from the (UNIVERSITY) have published the research: main topic, in the Journal: (JOURNAL) of 10/06/2015
- how: Most of the information used in this study was derived from retrospective real-world data that were not collected systematically or prospectively.
SUMMARY
K Chronic myelomonocytic leukemia (CMML) is a rare, genotypically and phenotypically heterogenous hematologic malignancy of elderly people with an intrinsic risk to progress and transform into secondary acute myeloid leukemia (AML). With regard to the presence of myeloproliferation, CMML was originally subdivided into myeloproliferative . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.